Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
MedPlus Health Services Ltd. ( (IN:MEDPLUS) ) has issued an update.
MedPlus Health Services Ltd. announced that its subsidiary, Optival Health Solutions Private Limited, has received a suspension order for a drug license at a store in Tamil Nadu. The suspension, issued by the Drugs Control Administration, Zone-IV, Tamil Nadu, is for three days and is expected to result in a potential revenue loss of approximately Rs 2.25 lakhs. This development could impact the company’s operations in the region, highlighting regulatory challenges in maintaining compliance with drug and cosmetics regulations.
More about MedPlus Health Services Ltd.
MedPlus Health Services Ltd. operates in the healthcare industry, primarily focusing on providing pharmaceutical products and health services. The company is based in Hyderabad, India, and is known for its extensive network of retail pharmacy outlets across the country.
YTD Price Performance: -11.59%
Average Trading Volume: 7,571
Current Market Cap: 90.91B INR
Find detailed analytics on MEDPLUS stock on TipRanks’ Stock Analysis page.